Clinical Trial Update: Intraoperative ICG for Systemic Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating intraoperative ICG for systemic sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Duke University | Conditions: Systemic Sclerosis | Phase 4 | Status: WITHDRAWN